Stay updated on Pembrolizumab with Targeted Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.

Latest updates to the Pembrolizumab with Targeted Therapy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedEditorial updates in Publications clarify that entries are automatically filled from PubMed and the page revision is now v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page removed the general funding-status notice related to government funding lapses. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedMinor formatting adjustments and wording changes were made to the Study Details page, including layout tweaks to the Study Overview and Study Dates sections. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange Detected- Added a government operating status notice and a link to operating details, plus a new version tag (v3.2.0). - Removed references to older revision (v3.1.0) and two disease terms (Mucosa-associated lymphoma; B-cell chronic lymphocytic leukemia).SummaryDifference2%

- Check78 days agoChange DetectedTerminology updated from Malt lymphoma to Mucosa-associated lymphoma, with a minor version increment from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check92 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2; removed Back to Top link (minor UI change).SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Targeted Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.